Combination Tea of Vernonia Amygdalina Del. Leaves and Syzygium Polyanthum Leaves as Complementary Therapy for Type 2 Diabetes Mellitus

Type 2 diabetes mellitus (T2DM) is a global health problem that increase every year. This study aims to test the effectiveness of a combination of African leaf and bay leaf tea as a complementary therapy for type 2 diabetes mellitus (TEDAS). This experimental research used mice induced with alloxan. Treatment and observation of antidiabetic effects were carried out for 12 days of treatment and KGD was measured every 3 days. There were 6 test groups including positive control using glibenclamide, negative control, no treatment, TEDAS1, TEDAS2 and TEDAS3. Phytochemical screening shows that TEDAS contains secondary metabolite compounds including tannins, alkaloids, flavonoids and saponins. The results showed that all TEDAS groups significantly reduced blood glucose levels. KGD examination on day 12 showed that the KGD in the group without treatment was 87, negative control 126 mg/dL, positive control 90 mg/dL, TEDASI 95 mg/dL, TEDAS2 91 mg/dL, and TEDAS3 96 mg/dL. The most effective group is TEDAS2 with glibenclamide + DA 100mg/Kgbb + DS 50mg/Kgbb treatment. Research indicates that TEDAS is effective as a complementary therapy for T2DM.

Authors

Institutions

Publication Details

Journal
JURNAL FARMASIMED (JFM)
Published
2024-10-31
DOI
https://doi.org/10.35451/jfm.v7i1.2303
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combination Tea of Vernonia Amygdalina Del. Leaves and Syzygium Polyanthum Leaves as Complementary Therapy for Type 2 Diabetes Mellitus

Haryanti Sinaga, Hazira Yulistia Tanjung, Wahyudi Wahyudi
JURNAL FARMASIMED (JFM)
Natural Antidiabetic Agents Studies
article

Combination Tea of Vernonia Amygdalina Del. Leaves and Syzygium Polyanthum Leaves as Complementary Therapy for Type 2 Diabetes Mellitus

Haryanti Sinaga, Hazira Yulistia Tanjung, Wahyudi Wahyudi
article en

Abstract

Type 2 diabetes mellitus (T2DM) is a global health problem that increase every year. This study aims to test the effectiveness of a combination of African leaf and bay leaf tea as a complementary therapy for type 2 diabetes mellitus (TEDAS). This experimental research used mice induced with alloxan. Treatment and observation of antidiabetic effects were carried out for 12 days of treatment and KGD was measured every 3 days. There were 6 test groups including positive control using glibenclamide, negative control, no treatment, TEDAS1, TEDAS2 and TEDAS3. Phytochemical screening shows that TEDAS contains secondary metabolite compounds including tannins, alkaloids, flavonoids and saponins. The results showed that all TEDAS groups significantly reduced blood glucose levels. KGD examination on day 12 showed that the KGD in the group without treatment was 87, negative control 126 mg/dL, positive control 90 mg/dL, TEDASI 95 mg/dL, TEDAS2 91 mg/dL, and TEDAS3 96 mg/dL. The most effective group is TEDAS2 with glibenclamide + DA 100mg/Kgbb + DS 50mg/Kgbb treatment. Research indicates that TEDAS is effective as a complementary therapy for T2DM.

JURNAL FARMASIMED (JFM)Vol. 7(1)
Universitas Islam Negeri Sumatera Utara (ID)
Good health and well-being
Openalex Percentile: Top 68%
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Combination Tea of Vernonia Amygdalina Del. Leaves and Syzygium Polyanthum Leaves as Complementary Therapy for Type 2 Diabetes Mellitus — Haryanti Sinaga, Hazira Yulistia Tanjung, et al. · JURNAL FARMASIMED (JFM) (2024) | TGRS Research Map | TGRS